Abcam Share Forecast, Price & News

Abcam (LON:ABC) Frequently Asked Questions

Is Abcam a buy right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Abcam in the last year. There are currently 5 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Abcam stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ABC, but not buy additional shares or sell existing shares.
View analyst ratings for Abcam or view top-rated stocks.

How has Abcam's stock price been impacted by Coronavirus (COVID-19)?

Abcam's stock was trading at GBX 1,140 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ABC stock has increased by 46.7% and is now trading at GBX 1,672.
View which stocks have been most impacted by COVID-19.

What price target have analysts set for ABC?

5 brokers have issued 12 month target prices for Abcam's stock. Their forecasts range from GBX 1,300 to GBX 1,530. On average, they anticipate Abcam's stock price to reach GBX 1,442 in the next twelve months. This suggests that the stock has a possible downside of 13.8%.
View analysts' price targets for Abcam or view top-rated stocks among Wall Street analysts.

Who are Abcam's key executives?

Abcam's management team includes the following people:

• Mr. Alan Thomas Hirzel BS, MS, MBA, CEO & Exec. Director (Age 53, Pay $1.05M)
• Mr. Michael Shaun Baldock, CFO & Director (Age 57, Pay $528.8k)
• Mr. Mark Dermody, Interim CIO
• James Staveley, VP of Investor Relations
• Marc Perkins, Gen. Counsel & Company Sec.
• Dr. Cheri L. Walker, Sr. VP of Corp. Devel.
• Mr. Nick Skinner, Sr. VP of HR
• Mr. Mark Bushfield, Sr. VP of Research & Innovation
• Ms. Kirstie Speck BBusSc, Head of Consumer Insights
• Ms. Yvonne Chien, Sr. VP of Customer Experience

Who are some of Abcam's key competitors?

Some companies that are related to Abcam include Halozyme Therapeutics (HALO), BTG (BTG), Genus (GNS), Trillium Therapeutics (TRIL), Cronos Group (CRON), Concordia International (CXR), MorphoSys (MOR), Vaxxinity (VAXX), Oxford Biomedica (OXB), Biotest Aktiengesellschaft (BIO), PureTech Health (PRTC), Ergomed (ERGO), Inventiva (IVA), BELLUS Health (BLU) and Pfenex (PFNX).
View all of ABC's competitors.

What other stocks do shareholders of Abcam own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Abcam investors own include Hawkins (HWKN), CA (CA), Endologix (ELGX), BlackRock (BLK), Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW), Athabasca Oil (ATH), HSBC (HSBA), Royal Dutch Shell (RDSA) and Centrica (CNA).

What is Abcam's stock symbol?

Abcam trades on the London Stock Exchange (LON) under the ticker symbol "ABC."

How do I buy shares of Abcam?

Shares of ABC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Abcam's stock price today?

One share of ABC stock can currently be purchased for approximately GBX 1,672.

How much money does Abcam make?

Abcam has a market capitalization of £3.79 billion and generates £297.70 million in revenue each year.

How many employees does Abcam have?

Abcam employs 21,500 workers across the globe.

What is Abcam's official website?

The official website for Abcam is www.abcam.com.

Where are Abcam's headquarters?

Abcam is headquartered at 330 Cambridge Science Park, CAMBRIDGE, CB4 0FL, United Kingdom.

How can I contact Abcam?

Abcam's mailing address is 330 Cambridge Science Park, CAMBRIDGE, CB4 0FL, United Kingdom. The company can be reached via phone at +44-1223-696000.